| Ashley Harris, | |
|
521 S Summit Ave, Charlotte, NC 28208-4525 | |
| (704) 835-6477 | |
| Not Available |
| Full Name | Ashley Harris |
|---|---|
| Gender | Female |
| Speciality | Integrative Medicine |
| Location | 521 S Summit Ave, Charlotte, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932895356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP0504X | Podiatrist - Public Medicine | M108398 (North Carolina) | Secondary |
| 202D00000X | Integrative Medicine | M108398 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Harris, 521 S Summit Ave # 521, Charlotte, NC 28208-4525 Ph: (704) 835-6477 | Ashley Harris, 521 S Summit Ave, Charlotte, NC 28208-4525 Ph: (704) 835-6477 |
News Archive
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 2 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), the second global, Phase 3 clinical trial of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria.
Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies.
There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at
Researchers at the University of Leicester have recorded a rare type of pollen that is a potent trigger of hayfever and asthma symptoms at record levels for the first time in four decades.
A large new study confirms that people with severe mental disorders — such as schizophrenia or other psychotic disorders — are 25 percent to 40 percent more prone to die from heart disease than people without mental illness are.
› Verified 5 days ago